Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
9 studies found for:    13007
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: vedolizumab;   Other: Placebo
2 Recruiting Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
Condition: Essential Thrombocythaemia
Interventions: Drug: Anagrelide retard;   Drug: Placebo
3 Completed Sole Local Anesthetic Versus Opioid Plus Local Anesthesia in Epidural Labor Analgesia
Condition: Pain
Interventions: Drug: Sole local anesthetic;   Drug: Sufentanil  (Opioid plus local anesthetic);   Drug: Ropivacaine
4 Active, not recruiting Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)
Condition: Rheumatoid Arthritis
Interventions: Drug: Bredinin tablet 150mg;   Drug: Bredinin tablet 50mg
5 Recruiting Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Pomalidomide;   Drug: Dexamethasone
6 Recruiting Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease
Condition: Moderate to Severe Crohn's Disease
Intervention: Biological: ADALIMUMAB
7 Completed Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
Condition: Hepatitis B
Intervention: Other: Data collection
8 Recruiting Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
Condition: Asthma
Interventions: Drug: Fluticasone propionate (Fp) MDPI;   Drug: Fluticasone propionate/Salmeterol (FS) MDPI;   Drug: Placebo MDPI
9 Recruiting GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
Conditions: Stroke;   Atrial Fibrillation

Indicates status has not been verified in more than two years